| Type | Public company (BSE: 532322NSE: ELDERPHARM) |
|---|---|
| Industry | Pharmaceuticals, Drugs & healthcare |
| Founded | 1989 [1] |
| Founder(s) | Mr. Jagdish Saxen |
| Headquarters | Mumbai, Maharashtra [2], India |
| Key people | Jagdish Saxena, Managing Director |
| Products | Medicines and Vaccines |
| Revenue | 833.02 crore (US$158.27 million) (2010-2011) [3] |
| Employees | 4300 [4] |
| Subsidiaries | NeutraHealth,[5] Elvista [6] |
| Website | Official Website |
Elder Pharmaceuticals (BSE: 532322NSE: ELDERPHARM) is one of the leading pharmaceutical company headquartered in Mumbai, Maharashtra.[7] Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women’s Healthcare, Wound Care and Nutraceuticals. It has 6 manufacturing plants in India & 1 in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.[8]
In 1989, Mr. Jagdish Saxena sets up Elder Pharmaceuticals in Mumbai. The first manufacturing plant was set up in 1989, at Nerul. It was listed on Bombay Stock Exchange and National Stock Exchange in 2000. It was founded by Mr. Saxena, when he lost his job due to shut down of pharma division of company for which he were working.[9]